The Precision Peptide Company Inc.

Over the past ninety days, The Precision Peptide Company Inc. recorded three insider trading transactions, all involving director Pratapvir Sandhu. These acquisitions totaled 166,725 CAD in value. No sales occurred during this period, reflecting exclusively purchasing activity by a single board member across multiple dates in June and July.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Sandhu, Pratapvir Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
306.93
Quantity 23,573 +27.8%
Value CA$4,269,110
3.8
Sandhu, Pratapvir Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
440.82
Quantity 33,317 +3.4%
Value CA$557,707
3.8
Sandhu, Pratapvir Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
494.16
Quantity 88,789 +36.5%
Value CA$994,370
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-07-17 2026-07-17 B Purchase

Director of Issuer

Non-Executive Director
23,573 +27.8%
306.93
CA$4,269,110
23,573 +27.8% 306.93 CA$4,269,110
2026-07-17 2026-07-17 B Purchase

Director of Issuer

Non-Executive Director
33,317 +3.4%
440.82
CA$557,707
33,317 +3.4% 440.82 CA$557,707
2026-06-23 2026-06-02 B Purchase

Director of Issuer

Non-Executive Director
88,789 +36.5%
494.16
CA$994,370
88,789 +36.5% 494.16 CA$994,370
Explore more

More insider trading research around The Precision Peptide Company Inc.